Existing data suggest that m6A has prognostic value and affects immune cell infiltration in brain cancers [22–27], and a well-characterized lncRNA GAS5 has been shown to have an m6A-dependent role in tumor suppression in colorectal cancer (CRC). Here, GAS5 is linked to colorectal carcinoma.